Using targeted therapy to treat breast cancer
Proton therapy is a newer type of radiation therapy that uses energy from positively charged particles called protons. Studies have suggested that proton therapy may cause fewer side effects than traditional radiation, since doctors can better control where the proton beams deposit their energy.
Unlike traditional X-ray radiation, proton beam therapy can more precisely target tumors, sparing more normal tissue.
"The main advantage is this idea of sparing normal tissues and reducing late side effects of treatment. This is especially important in breast cancer," says Dr. Robert Mutter, a Mayo Clinic radiation oncologist.
Dr. Mutter says because the heart sits right behind breast tissue, using protons to target breast cancer tumors can reduce the radiation dose to the heart and lungs, and may offer better outcomes for patients.
"We think that that's going to lead to less risk of heart disease, and less risk of lung disease or second cancers in the future," says Dr. Mutter.
In recent years, Dr. Mutter says studies have shown the potential to safely shorten the course of radiation treatment for breast cancer.
"We think that protons may be a way that we can do this even more effectively because protons expose less normal tissues. If we can reduce the number of daily treatments, that means that my patients are able to be back with their families, or back at their work or the things that they love to do, and not coming in for their treatment," he says.
Watch this "Mayo Clinic Minute" video to hear Dr. Mutter explain the potential long-term advantages of using targeted therapy to treat breast cancer:
______________________________________
For the safety of its patients, staff and visitors, Mayo Clinic has strict masking policies in place. Anyone shown without a mask was either recorded prior to COVID-19 or recorded in a nonpatient care area where social distancing and other safety protocols were followed.
Learn more
Learn more about breast cancer and find a breast cancer clinical trial at Mayo Clinic.
Join the Breast Cancer Group on Mayo Clinic Connect.
A version of this article originally appeared on the Mayo Clinic News Network.
Related Posts
People with early-stage triple-negative breast cancer and high levels of immune cells in their tumors may have a lower risk of recurrence and better survival rates.
Dr. Maria Linnaus discusses the link between obesity and cancer risk and how bariatric surgery may reduce that risk.
Dr. Dawn Mussallem, a Mayo Clinic lifestyle medicine expert, says consuming soy products in moderation can be beneficial.